Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2005-09-01 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-PAUL (60650), Oise
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE SIMEON : revenue, balance sheet and financial ratios
PHARMACIE SIMEON is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-PAUL (60650),
this company of category PME
shows in 2023 a revenue of 2.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE SIMEON (SIREN 484488507)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
2 641 703 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
198 468 €
864 €
103 040 €
79 196 €
65 645 €
67 563 €
-144 237 €
-304 265 €
EBITDA
N/C
42 689 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
0.0%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE SIMEON generates positive net income of 198 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
198 468 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 94%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
94.339%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
46.512%
Solvency indicators evolution PHARMACIE SIMEON
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
190.333
234.423
209.107
187.509
164.472
137.607
124.348
94.339
Financial autonomy
32.789
24.766
28.13
30.814
33.279
36.742
38.447
46.512
Repayment capacity
None
None
None
None
None
None
37.128
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
1.352%
None%
Sector positioning
Debt ratio
94.342024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average-5 pts over 3 years
In 2024, the debt ratio of PHARMACIE SIMEON (94.34) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
46.51%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average+10 pts over 3 years
In 2024, the financial autonomy of PHARMACIE SIMEON (46.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
37.13 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Watch
In 2023, the repayment capacity of PHARMACIE SIMEON (37.13) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 1037.51. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
1037.514
Liquidity indicators evolution PHARMACIE SIMEON
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
565.377
148.15
174.809
208.56
214.255
216.883
179.56
1037.514
Interest coverage
None
None
None
None
None
None
26.885
None
Sector positioning
Liquidity ratio
1037.512024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Excellent+19 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE SIMEON (1037.51) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
26.89x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent
In 2023, the interest coverage of PHARMACIE SIMEON (26.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE SIMEON
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
509 135 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
45
0
Customer payment term (days)
0
0
0
0
0
0
3
0
Supplier payment term (days)
0
0
0
0
0
0
51
0
Positioning of PHARMACIE SIMEON in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE SIMEON is estimated at
2 770 760 €
(range 1 929 513€ - 4 145 215€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1929k€2770k€4145k€
2 770 760 €Range: 1 929 513€ - 4 145 215€
NAF 5 année 2024
Valuation method used
Net Income Multiple
198 468 €
×
14.0x
=2 770 760 €
Range: 1 929 513€ - 4 145 215€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE SIMEON with other companies in the same sector:
The revenue of PHARMACIE SIMEON in 2023 is 2.6 M€.
Is PHARMACIE SIMEON profitable?
Yes, PHARMACIE SIMEON generated a net profit of 198 k€ in 2024.
Where is the headquarters of PHARMACIE SIMEON ?
The headquarters of PHARMACIE SIMEON is located in SAINT-PAUL (60650), in the department Oise.
Where to find the tax return of PHARMACIE SIMEON ?
The tax return of PHARMACIE SIMEON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE SIMEON operate?
PHARMACIE SIMEON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart